Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.43 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 5/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18822070 | 0.89 | SMPD1 (0.37) | SMPD1LPAR3LPAR2LPAR1TDP1 | |
| SCHEMBL1923665 | 0.89 | SMPD1 (0.46) | SMPD1LPAR3LPAR2LPAR1FDPS | |
| SCHEMBL31116893 | 0.87 | SMPD1 (0.40) | SMPD1LPAR3LPAR2LPAR1FDPS | |
| SCHEMBL2710380 | 0.85 | HMGCR (0.38) | SMPD1LPAR3LPAR2LPAR1LMNA | |
| SCHEMBL5964008 | 0.85 | SMPD1 (0.35) | SMPD1LPAR3LPAR2LPAR1 | |
| SCHEMBL27626927 | 0.85 | SMPD1 (0.52) | SMPD1LPAR3LPAR2LPAR1FDPS | |
| SCHEMBL5964459 | 0.82 | SMPD1 (0.48) | SMPD1LPAR3LPAR2LPAR1FDPS | |
| SCHEMBL1921756 | 0.81 | SMPD1 (0.42) | SMPD1LPAR3LPAR2LPAR1LMNA | |
| SCHEMBL28544090 | 0.79 | SMPD1 (0.45) | SMPD1LPAR3LPAR2LPAR1LMNA | |
| SCHEMBL29245249 | 0.79 | SMPD1 (0.55) | SMPD1LPAR3LPAR2LPAR1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115850787-A | Recyclable aramid nanofiber aerogel, and preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2023-03-28 | — | — | CN | claimed |
| EP-2403050-B1 | Battery of electrochemical generators including a foam as a filling material between generators | ACCUMULATEURS FIXES (FR) | 2018-07-18 | — | — | EP | claimed |
| US-7494716-B2 | Method for the anodic electrophoretic enamelling and electrophoretic paints | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-02-24 | — | — | US | claimed |
| EP-1038900-B1 | Double metal cyanide catalysts for the production of polyetherpolyols | BAYER MATERIALSCIENCE AG (DE) | 2004-07-14 | — | — | EP | claimed |
| EP-1248823-B1 | METHOD FOR THE ANODIC ELECTROPHORETIC ENAMELLING AND ELECTROPHORETIC PAINTS | DU PONT (US) | 2004-03-17 | — | — | EP | claimed |
| US-20030004231-A1 | Method for the anodic electrophoretic enamelling and electrophoretic paints | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-01-02 | — | — | US | claimed |
| US-6468939-B1 | ESTERS OF PHOSPHORIC ACID, PHOSPHOROUS ACID, PHOSPHONIC ACID, PHOSPHONOUS ACID, PHOSPHINIC ACID OR PHOSPHINOUS ACID; COMPLEXING LIGANDS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-10-22 | — | — | US | claimed |
| EP-0026736-B1 | PROCESS FOR PREPARING 2,3,5-TRICHLOROPYRIDINE AND AMMONIUM SALTS OF THE METHYL ESTER OF METHANE PHOSPHONIC ACID, AND THEIR PREPARATION | CIBA-GEIGY AG (CH) | 1984-12-05 | — | — | EP | claimed |
| EP-0026737-B1 | PROCESS FOR PRODUCING 2,3,5,6-TETRACHLOROPYRIDINE | CIBA-GEIGY AG (CH) | 1983-03-09 | — | — | EP | claimed |
| US-4259495-A | Process for producing 2,3,5,6-tetrachloropyridine | CIBA-GEIGY CORPORATION (US) | 1981-03-31 | — | — | US | claimed |
| US-4258194-A | Process for producing 2,3,5-trichloropyridine | CIBA-GEIGY CORPORATION (US) | 1981-03-24 | — | — | US | claimed |
| EP-4730479-A2 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-20250391941-A1 | PROCESS FOR THE RECOVERY AND PURIFICATION OF GRAPHITE FROM SPENT BATTERIES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2025-12-25 | — | — | US | disclosed |
| EP-4652135-A1 | METHOD FOR THE GENERATION OF A PHOSPHORUS TRIFLUORIDE, A HEXAFLUOROPHOSPHATE, A PHOSPHORUS TRIHALOGENIDE, PHOSPHORIC ACID OR A PHOSPHORUS-COMPRISING ORGANIC COMPOUND | Universität Regensburg, in Vertretung des Freistaats Bayern (DE) | 2025-11-26 | — | — | EP | disclosed |
| US-20250246685-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | KYOTO UNIVERSITY (JP) | 2025-07-31 | — | — | US | disclosed |
| US-4327040-A | BASIC CATALYZED REACTION OF PROPARGYL ALCOHOL WITH A PHOSPHORIC ACID CHLORIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1982-04-27 | — | — | US | disclosed |
| US-4325873-A | Process for the preparation of styryl-cyclopropanecarboxylic acid esters and intermediate products for this process | BAYER AKTIENGESELLSCHAFT (DE) | 1982-04-20 | — | — | US | disclosed |
| US-4259495-A | Process for producing 2,3,5,6-tetrachloropyridine | CIBA-GEIGY CORPORATION (US) | 1981-03-31 | — | — | US | disclosed |
| US-4258194-A | Process for producing 2,3,5-trichloropyridine | CIBA-GEIGY CORPORATION (US) | 1981-03-24 | — | — | US | disclosed |
| US-4151050-A | Process for producing sulfones | KERNFORSCHUNGSANLAGE JULICH GESELLSCHAFT (DE) | 1979-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250391941-A1 | PROCESS FOR THE RECOVERY AND PURIFICATION OF GRAPHITE FROM SPENT BATTERIES | CD274, MARK1, PDCD1 | SMPD1 3333/4885LPAR3 2736/4885LPAR2 2560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.